BlackRock Fund Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $127K | Sell |
44,002
-290,601
| -87% | -$839K | ﹤0.01% | 3543 |
|
|
2016
Q3 | $1.97M | Buy |
334,603
+18,881
| +6% | +$111K | ﹤0.01% | 3161 |
|
|
2016
Q2 | $947K | Sell |
315,722
-334,982
| -51% | -$1M | ﹤0.01% | 3267 |
|
|
2016
Q1 | $3.49M | Buy |
650,704
+5,194
| +0.8% | +$27.8K | ﹤0.01% | 2914 |
|
|
2015
Q4 | $7.66M | Buy |
645,510
+252,794
| +64% | +$3M | ﹤0.01% | 2599 |
|
|
2015
Q3 | $3.22M | Sell |
392,716
-4,468
| -1% | -$36.7K | ﹤0.01% | 2990 |
|
|
2015
Q2 | $5.54M | Buy |
397,184
+292,195
| +278% | +$4.08M | ﹤0.01% | 2864 |
|
|
2015
Q1 | $2.52M | Buy |
104,989
+1,805
| +2% | +$43.4K | ﹤0.01% | 3088 |
|
|
2014
Q4 | $1.7M | Buy |
103,184
+14,715
| +17% | +$242K | ﹤0.01% | 3179 |
|
|
2014
Q3 | $1.13M | Buy |
88,469
+568
| +0.6% | +$7.23K | ﹤0.01% | 3185 |
|
|
2014
Q2 | $1.98M | Sell |
87,901
-8,723
| -9% | -$197K | ﹤0.01% | 3128 |
|
|
2014
Q1 | $2.73M | Buy |
+96,624
| New | +$2.73M | ﹤0.01% | 3090 |
|